An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.
30 March 2026
While underreporting remains a persistent global challenge, innovative approaches are showing promise in different regions
18 February 2026
Online psychedelic forums hold untapped safety data. AI analysis of user narratives could help pharmacovigilance systems detect risks missed by traditional reporting.
13 November 2025
MUEs are typically used to improve the safety of drugs, however, may they also have a role in measuring the adherence to risk minimisation measures?
06 August 2025